Short Course on Wellness – What You Should Know

What You Need to Know About Bipolar Depression

The bipolar disorder is a kind of condition which affects all types of people. Children and adults are affected by this condition. This is a fact that you should know. The women are going to suffer the most from such type of depression which is called bipolar depression disorder.

This is not really strange or far-fetched in any case because even if the women would suffer from the regular bipolar type of depression or depressive disorder, they are going to spend more time depressed than they would do being manic. Not just women are depressive but the men would also get affected by such kind of condition.

Such bipolar kind of disorder is called manic depression since such is one mental condition in which you would interchange often between the phases of mania as well as depression. If you suffer from such bipolar depression, you won’t have to spend a lot of time being manic as you spend getting depressed.

This type of depression is one form of disorder and you should understand that it is really easy to wrongly diagnose as bipolar disorder due to the similarity in their symptoms. Because of this, the doctor must have to keep you around for a long time when they would try to diagnose the condition that you have. It certainly won’t be flattering to either of you when you are treated for a wrong thing.

The bipolar affective disorder is another name for such bipolar disorder or the manic-depressive illness. However, you don’t want to mistake such for bipolar depression disorder. This is closely related with the symptoms of the depressive phase of the bipolar disorder but just a few of the mania.

Monotherapy trials against the placebo is the gold-standard design when determining the efficacy in treating bipolar depression. If the efficacy would get proven as monotherapy, those new compounds can be tested in the adjunctive-medication placebo-controlled trials. Those younger adults, without such established need for the long-term medication can be suitable for those clinical trials that require placebo-controls. The switch to mania or hypomania can be the consequence of such active treatment for the bipolar depression.

Some medications like the tricyclic antidepressants and the venlafaxine can be more likely to prove switch as compared to the others but the increased rate of the switch can’t be seen until about 10 weeks of treatment. Thus, the 12-week trials against placebo are needed to determine the risk of switch and establish the continuing effects. You have to know that such careful assessment at six to eight weeks are needed to guarantee that the patients who fail to respond won’t continue in the study for such unacceptable periods of time.